Summary by Moomoo AI
REMEGEN Pharmaceutical (Yantai) Co., Ltd. announces that a Board of Directors meeting will be held on March 27, 2025 (Thursday), with the main agenda including the review and approval of the 2024 annual performance report and its publication, as well as considering the dividend policy (if any).The meeting will be chaired by Mr. Wang Weidong, Chairman and Executive Director, and the Board of Directors members attending will include executive directors, non-executive directors, and independent non-executive directors.
Comment(0)
Reason For Report